TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs Platform
AI Overview
Technology licensing for Bacterial Lipid Nanodiscs Platform enabling safe study of bacterial membranes in nanoscale format for vaccine design and antimicrobial discovery without live pathogen handling.
This summary is AI-generated from the official solicitation.
Key Details
Official Description
The Bacterial Lipid Nanodiscs Platform developed by Los Alamos National Laboratory provides a new way to study entire bacterial membranes in a controlled, nanoscale format derived directly from native lipid extracts. Researchers gain access to membrane components that typically remain difficult to isolate, stabilize or analyze, enabling more accurate evaluation of immunogenic lipids and membrane‑associated targets. The platform offers a safer alternative to handling live high‑risk pathogens whil...
Change History
TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs Platform
New SAM.gov opportunity: TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs Platform
Similar Opportunities
Get Alerts for Opportunities Like This
RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.
Start Free Trial